RecruitingDiabetesType 1 Diabetes
Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression
Eligible age
18–64 yrs
Accepts
All genders
Locations
2 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This project will evaluate a telemedicine-delivered, Unified Protocol for Cognitive-Behavioral Therapy (UP-CBT) enhanced with continuous glucose monitor (CGM) review to target anxiety and depressive symptoms and glycemic control in adults with type 1 diabetes.
Sponsor: Albert Einstein College of Medicine
You may qualify if…
- ✓ Type 1 diabetes (T1D) duration ≥ 6 months
- ✓ 18-64 years old
- ✓ English- or Spanish-speaking
- ✓ Anxiety or depressive mood disorder as per structured diagnostic interview.
You may not qualify if…
- ✕ Developmental or sensory disability interfering with participation
- ✕ Current pregnancy
- ✕ Bipolar disorders, psychotic disorders, severe eating disorders, severe substance abuse disorders, or acute suicidal risk or self-harm
- ✕ Use of medications or recent medical procedures that would impact glycemic control or use of continuous glucose monitoring (CGM) over the study
- ✕ Received cognitive behavioral therapy (CBT) in last year or plans to initiate CBT; (6) temporary exclusion for recent initiation of psychotropic medication - must be on a stable dose for 6 weeks prior to enrollment.
Where it's recruiting
Massachusetts
Boston
New York
The Bronx
Source: ClinicalTrials.gov · NCT05734313 · last updated 2025-10-30